← Browse by Condition
Medical Condition
neurodevelopmental disorders
Total Trials
9
Recruiting Now
9
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for neurodevelopmental disorders sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — neurodevelopmental disorders Clinical Trials
How many clinical trials are currently recruiting for neurodevelopmental disorders?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for neurodevelopmental disorders, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for neurodevelopmental disorders?
neurodevelopmental disorders research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a neurodevelopmental disorders clinical trial?
Eligibility criteria for neurodevelopmental disorders trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07493096
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
Healing Hope International
NCT05527080
Recruiting
Enrollment
250 pts
Location
Finland
Sponsor
Helsinki University Central Ho...
NCT05154799
Recruiting
Enrollment
280 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06175104
Recruiting
Enrollment
50 pts
Location
United States, Austr...
Sponsor
Children's Hospital Medical Ce...
NCT06559267
Recruiting
Enrollment
350 pts
Location
United States
Sponsor
University of Washington
NCT06111898
Recruiting
Enrollment
348 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
NCT04964206
Recruiting
Enrollment
4,645 pts
Location
China
Sponsor
Dong-Xin Wang
NCT05658965
Recruiting
Enrollment
50 pts
Location
France
Sponsor
University Hospital, Lille
NCT06327906
Recruiting
Enrollment
6,000 pts
Location
China
Sponsor
Qilu Hospital of Shandong Univ...
Related Conditions
autism spectrum disorder (2) neurodevelopmental disorders ndd (1) neurodevelopmental disorders and developmental abnormalities (1) developmental delay disorder (1) cerebral palsy cp (1) cerebral palsy hemiparetic cerebral palsy spasticity gait disorders neurologic postural balance impairment (1) cerebral palsy infantile (1) cerebral palsy spastic hemiplegic (1) cerebral palsy dyskinetic (1) autism spectrum disorder asd (1) hypoxic ischemic encephalopathy (1) hypoxic ischemic encephalopathy hie (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology